NM_000330.4:c.304C>T
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PS4PP1_StrongPP3_StrongPP4
This summary comes from the ClinGen Evidence Repository: The NM_000330.4(RS1):c.304C>T variant is a missense variant encoding the substitution of Arginine with Tryptophan at amino acid 102. This variant is present in gnomAD v.4.1.0 at a frequency of 0.000008256 among hemizygous individuals, with 3 variant alleles / 363368 total hemizygous alleles, which is between the ClinGen X-linked IRD VCEP PM2_Supporting and BS1 thresholds of <0.000002 and >0.00002 and fails to meet these criteria. The computational predictor REVEL gives a score of 0.958, which is above the ClinGen X-linked IRD VCEP threshold of >0.932 and predicts a damaging effect on RS1 function (PP3_strong). The computational splicing predictor SpliceAI gives a delta score of 0.01 Acceptor Gain, which is below the ClinGen X-linked IRD VCEP threshold of >0.2 and does not predict that the variant disrupts RS1 splicing. The variant has been reported to segregate with retinal dystrophy through 3 meioses in a family including two affected brothers and 5 other affected members (PP1_strong; PMID:36695495, 9326935, 16901436, 24634885). At least one proband harboring this variant exhibits a phenotype including appearance of schisis and reduced visual acuity before age 13 years, which together are specific for X-linked retinoschisis (5 points, PMID:24634885, PP4). This variant has been reported in at least 5 apparently unrelated probands meeting one of the PS4 requirements of a male diagnosed with X-linked retinoschisis (PMIDs: 33124204, 9326935, 22245991, 36695495, 28348004, 35456481, PS4). In summary, this variant is classified as pathogenic for X-linked retinoschisis based on the ClinGen X-linked Inherited Retinal Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RS1 Version 1.0.0: PP3_strong, PP1_strong, PS4, and PP4 (date of approval 01/24/2025). LINK:https://erepo.genome.network/evrepo/ui/classification/CA226667/MONDO:0010725/126
Frequency
Consequence
NM_000330.4 missense
Scores
Clinical Significance
Conservation
Publications
- CDKL5 disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 2Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- precocious pubertyInheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000330.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RS1 | TSL:1 MANE Select | c.304C>T | p.Arg102Trp | missense | Exon 4 of 6 | ENSP00000369320.3 | O15537 | ||
| CDKL5 | TSL:1 | c.2797+1123G>A | intron | N/A | ENSP00000369325.3 | O76039-1 | |||
| CDKL5 | TSL:1 | c.2797+1123G>A | intron | N/A | ENSP00000369332.3 | O76039-1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD2 exomes AF: 0.00000546 AC: 1AN: 183299 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000546 AC: 6AN: 1097960Hom.: 0 Cov.: 31 AF XY: 0.00000826 AC XY: 3AN XY: 363368 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 22
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at